The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Osteoporosis (Endocrine Aspects)

Hormonal imbalances reducing bone density and increasing fracture risk.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Endokrinoloji department. Book Appointment →

What is Osteoporosis (Endocrine Aspects)?

Osteoporosis is a systemic skeletal disease in which fracture risk increases due to reduced bone mass and disrupted bone microarchitecture. A T-score of -2.5 or lower on bone density (DXA) measurement defines osteoporosis.

Osteoporosis stands out endocrinologically in particular when: postmenopausal estrogen deficiency causes rapid bone loss; cortisol excess in Cushing syndrome, bone resorption in hyperparathyroidism, and accelerated bone turnover in hyperthyroidism contribute to bone loss. Hypogonadism is also an important cause in men.

Early detection and treatment of hormonal causes substantially reduces fracture risk. Fall prevention, nutrition, and exercise are indispensable parts of osteoporosis management.

Symptoms

Often silent; remains asymptomatic until a fracture
Loss of height and stooped posture (vertebral fractures)
Lower back or back pain (vertebral compression fracture)
Fractures from minor trauma or spontaneously (wrist, hip, spine)
Symptoms of the underlying hormonal cause
Tooth loss and jawbone thinning
Accelerated bone loss signs in postmenopausal women

Risk Factors

Female sex and menopause
Advanced age
Long-term corticosteroid use
Hormonal disorders: Cushing, hyperparathyroidism, hyperthyroidism, hypogonadism
Low calcium and vitamin D intake
Smoking and alcohol use
Sedentary lifestyle and low body weight

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • For bone density screening (DXA) after menopause
  • When a fracture occurs from low-energy trauma
  • Bone density follow-up during long-term corticosteroid use
  • Bone evaluation in Cushing, hyperparathyroidism, or hyperthyroidism diagnoses
  • Endocrinology consultation when T-score is -1.0 or lower

Treatment Methods

01
Calcium (1000-1200 mg/day) and vitamin D (800-2000 IU/day) supplementation
02
Bisphosphonates (alendronate, zoledronic acid): suppress bone resorption (first-line)
03
Denosumab: RANK-L inhibitor, an effective bone protector
04
Teriparatide (PTH analog): stimulates bone formation in severe osteoporosis
05
Evaluation of hormonal cause (estrogen deficiency) in postmenopausal women
06
Exercise (weight-bearing exercises) and fall-prevention programs

Which Department to Visit?

You can visit our Endokrinoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Endokrinoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.